Schedule 13G ownership disclosure
Core Laboratories Inc
Common Stock · CUSIP: 21867A105
Event date: 2026-09-30
- Filing-level shares
- 2,629,631.00
- Percent of class
- 5.7%
- EARNEST PARTNERS LLC
Shares: 2,629,631.00 · Class: 5.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001102578-26-000063
- Form type
- SCHEDULE 13G/A
- Filer
- Core Laboratories Inc. /DE/
- CIK
- CIK 1958086
- Filed
- Nov 13, 2026
- Reporting period
- Sep 30, 2026
- Description
- Schedule 13G beneficial ownership